bioinformatics developer

Requisition ID: 66650 Position Type: FT Permanent Workplace Arrangement: #LI-Onsite About Kerry Kerry is the world's leading taste and nutrition company for the food, beverage and pharmaceutical industries. Every day we partner with customers to create healthier, tastier and more sustainable products that are consumed by billions of people across the...

Requisition ID: 66651 Position Type: FT Permanent Workplace Arrangement: #LI-Onsite About Kerry Kerry is the world's leading taste and nutrition company for the food, beverage and pharmaceutical industries. Every day we partner with customers to create healthier, tastier and more sustainable products that are consumed by billions of people across the...

A focus of our research are Engineered Living Materials (ELMs), an emergent class of materials from the combination of inert materials and living organism, with huge potential for sustainable innovation in different technological fields. Across the institute, materials scientists, synthetic biologists and biophysicists cooperate to understand living and...

At Bayer we’re visionaries, driven to solve the world’s toughest challenges and striving for a world where ,Health for all, Hunger for none’ is no longer a dream, but a real possibility. We’re doing it with energy, curiosity and sheer dedication, always learning from unique perspectives of those around us, expanding our thinking, growing our...

About Apheris Apheris is an AI drug discovery company. We build federated data networks and customizable AI models across co-folding, binding affinity, ADMET, in vivo PK, and antibody developability. Our position is one no one else holds: models trained on proprietary pharma data that no public model can reach, and a platform that puts them to work inside...

Site Name: London The Stanley Building, Heidelberg, Switzerland - Zug, USA - Massachusetts - Cambridge Posted Date: Apr 20 2026 At GSK, we are actively working on building a future in which state-of-the-art software, Artificial Intelligence (AI) and Machine Learning (ML) enable us to develop new therapies and personalized medicines that drive better outcomes...

Site Name: London The Stanley Building, Heidelberg, Switzerland - Zug, USA - Massachusetts - Cambridge Posted Date: Apr 20 2026 At GSK, we see a world where advanced applications of Machine Learning and AI enable us to develop transformational medicines that drive better outcomes for patients at reduced cost and with fewer side effects. AI will also play a...